Efficacy & Safety Study of Nasalfent (Fentanyl Citrate Nasal Spray) for Treatment of Breakthrough Cancer Pain in Patients Taking Regular Opioids

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
Cancer patients taking regular medication for their pain often still have episodes of severe pain that \'break through\' despite their background pain treatment. Fentanyl is a strong, short-acting pain killer often used to treat this \'breakthrough\' pain. Nasalfent contains fentanyl in a patented drug delivery system called PecSys and is given via a simple nasal spray. This study will test the efficacy and safety of Nasalfent in the treatment of breakthrough cancer pain.
Epistemonikos ID: c6284b7f614686ddf27b3c65eaf00448651177f4
First added on: May 04, 2024